Not applicableUnknownNCT02992990What this trial is testingBladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and GradeWho this might be right forBladder Cancer Baylor College of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT04383743What this trial is testingPembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder CancerWho this might be right forStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8Muscle Invasive Bladder Carcinoma University of Washington 17
Not applicableAvailableNCT06443944What this trial is testingAn Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCGWho this might be right forNon-Muscle Invasive Bladder CancerUrothelial CarcinomaUrologic Cancer+1 more CG Oncology, Inc.
Early research (Phase 1)Active Not RecruitingNCT04432857What this trial is testingAN0025 and Pembrolizumab Combination in Advanced Solid TumorsWho this might be right forTriple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more Adlai Nortye Biopharma Co., Ltd. 63
Testing effectiveness (Phase 2)Study completedNCT03430895What this trial is testingEvaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary TractWho this might be right forNon-Transitional Cell Carcinoma of the Urothelial TractSmall Cell of the BladderAdenocarcinoma of the Bladder+2 more Memorial Sloan Kettering Cancer Center 15
Not applicableUnknownNCT05276167What this trial is testingHyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial CarcinomaWho this might be right forHigh-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaPerfusion; ComplicationsIntraoperative Complications Henan Cancer Hospital 40
Large-scale testing (Phase 3)Study completedNCT07279792What this trial is testingImplications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral ResectionWho this might be right forBladder (Urothelial, Transitional Cell) CancerNonmuscle Invasive Bladder CancerIrrigation+3 more Ain Shams University 150
Not applicableLooking for participantsNCT06991868What this trial is testingProspective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)Who this might be right forNMIBCMIBCUTUC Peking University First Hospital 300
Early research (Phase 1)Enrolling By InvitationNCT07218003What this trial is testingA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Who this might be right forNon Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more Rondo Therapeutics 149
Testing effectiveness (Phase 2)UnknownNCT04730232What this trial is testingTilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely ResectableWho this might be right forHigh-RiskNon-Muscle Invasive Bladder Urothelial Carcinoma Tianjin Medical University Second Hospital 63
Not applicableNot Yet RecruitingNCT06751667What this trial is testingXpert Bladder Monitor: a Non-Invasive Follow-Up Tool for Detecting Relapse in High Grade or High Risk Bladder CancerWho this might be right forBladder (Urothelial, Transitional Cell) CancerBladder CancerBladder Tumors+2 more Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 50
Testing effectiveness (Phase 2)Study completedNCT03914794What this trial is testingPemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk TumorsWho this might be right forBladder CancerNMIBCNon-Muscle Invasive Bladder Cancer+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Early research (Phase 1)Looking for participantsNCT06766266What this trial is testingIrinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines TreatmentWho this might be right forNon-Muscle Invasive Bladder Urothelial Carcinoma First Affiliated Hospital of Chongqing Medical University 18
Early research (Phase 1)Looking for participantsNCT07492628What this trial is testingDual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial CarcinomaWho this might be right forBladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+2 more Beijing Biotech 42
Not applicableLooking for participantsNCT07302230What this trial is testingHome-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER TrialWho this might be right forLocalized Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more University of Washington 100
Testing effectiveness (Phase 2)Study completedNCT02015104What this trial is testingStudy of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCGWho this might be right forBladder Cancer National Cancer Institute (NCI) 32
Early research (Phase 1)Study completedNCT04440943What this trial is testingThe PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced MalignanciesWho this might be right forNon-small Cell Lung CancerBreast CancerGastric Cancer+11 more Celldex Therapeutics 27
Early research (Phase 1)Active Not RecruitingNCT05768347What this trial is testingIntravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBCWho this might be right forUrothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma H. Lee Moffitt Cancer Center and Research Institute 9
Early research (Phase 1)Looking for participantsNCT07140315What this trial is testingDK222 Study at HopkinsWho this might be right forNon-Small Cell Lung CancerUrothelial Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Large-scale testing (Phase 3)Looking for participantsNCT05037279What this trial is testingEvaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)Who this might be right forBladder CancerBladder Cancer RecurrentNeoplasm Recurrence+3 more Verity Pharmaceuticals Inc. 540